May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Staphylococcal Enterotoxin B Enhances Experimental Autoimmune Uveoretinitis
Author Affiliations & Notes
  • H. Kohno
    Jikei Univ School of Medicine, Tokyo, Japan
    Ophthalmology,
  • T. Sakai
    Jikei Univ School of Medicine, Tokyo, Japan
    Ophthalmology,
  • K. Kitahara
    Jikei Univ School of Medicine, Tokyo, Japan
    Ophthalmology,
  • S. Saito
    Jikei Univ School of Medicine, Tokyo, Japan
    Molecular Immunology,
  • Footnotes
    Commercial Relationships H. Kohno, None; T. Sakai, None; K. Kitahara, None; S. Saito, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5130. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Kohno, T. Sakai, K. Kitahara, S. Saito; Staphylococcal Enterotoxin B Enhances Experimental Autoimmune Uveoretinitis. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5130.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: Staphylococcal enterotoxin B (SEB) is a member of superantigens which were delivered from bacteria, viruses and mycoplasmas. Superantigen was known as the most powerful T-cell activators, related to human autoimmune disease induction. In this study, we investigated the effect of SEB in experimental autoimmune uveoretinitis.

Methods:: Each of the mice were immunized with a subcutaneous injection of human interphotoreceptor retinoid-binding protein (IRBP) 1-20 emulsified in the same volume of complete Freund’s adjuvant, and then inoculated intra peritoneal with 1.5 µg of pertussis toxin. SEB (200µg) was administered by intravenous injection on day 10 post immunization. In the other experiment, anti-CD4 antibody (Ab) or anti-CD8 Ab were administered before and after SEB administration. EAU mice were examined every other day for clinical signs. All mice were sacrificed on day 18 post immunization and then histological assessment, IRBP specific T-cell proliferation and cytokine production assay were done.

Results:: EAU disease severity was clinically and histologically enhanced by SEB injection. Anti-CD4 Ab injection inhibited the enhancement induced by SEB but not by anti CD8 Ab injection. Further, IRBP specific T-cell proliferation and IFN-γ production was enhanced in SEB injected group.

Conclusions:: The present study indicated that SEB is a factor related to EAU disease severity.

Keywords: uveitis-clinical/animal model • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×